Back to TEVA Stock Lookup

Teva Pharma (TEVA) –

Dec 19, 2014 09:08 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 19
Dec 19, 2014 08:02 AM Teva Pharma (TEVA) Receives FDA Approval of QNASL as AR-Related Nasal Symptoms Treatment
Dec 19, 2014 08:00 AM Teva Announces FDA Approval of QNASL® (Beclomethasone Dipropionate) Nasal Aerosol for Treatment of Children with Seasonal and Perennial Allergic Rhinitis
Dec 12, 2014 10:59 AM Notable Analyst Rating Changes 12/12: (GPRO) (TEVA) (DTE) Upgraded; (GDP) (ORCL) (MS) Downgraded
Dec 12, 2014 08:21 AM Sterne Agee Upgrades Teva Pharma (TEVA) to Buy
Dec 11, 2014 05:20 PM Market Wrap: Retail Sales Robust in Nov.; Staples, Office Depot Deal in the Works?; Two Notable IPOs Launch
Dec 11, 2014 07:03 AM Teva Pharma (TEVA) Guides FY15 Revenue Below Expectations
Dec 11, 2014 07:00 AM Teva Provides 2015 Business Outlook
Dec 11, 2014 07:00 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 11
Dec 11, 2014 06:01 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 10
Dec 10, 2014 08:35 AM Teva Pharma (TEVA) Launches First FDA-Approved, Genetic Celebrex
Dec 10, 2014 08:30 AM Teva Announces Launch of First Generic Celebrex® Capsules in the United States
Dec 8, 2014 06:39 AM Teva Pharma (TEVA) PT Raised to $66 at BofA/Merrill Lynch
Dec 4, 2014 12:01 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 04
Dec 4, 2014 10:29 AM Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
Dec 1, 2014 04:27 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 01
Dec 1, 2014 03:46 PM Teva to Host 2015 Business Outlook Conference Call and Webcast on December 11, 2014
Dec 1, 2014 12:15 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 01
Dec 1, 2014 12:02 PM Teva Pharma (TEVA) Launches Generic Exforge HCT Tabs (NVS)
Dec 1, 2014 11:50 AM Teva Announces Launch of Generic Exforge HCT® Tablets in the United States
Nov 26, 2014 11:26 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Nov 26
Nov 26, 2014 11:13 AM Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors
Nov 21, 2014 08:18 AM Teva Pharma (TEVA) Receives Positive CHMP Opinion for Rasagiline Ratiopharm as Idiopathic PD Treatment
Nov 18, 2014 01:04 PM Teva (TEVA), Valeant (VRX) Deal Unlikely, BMO Analyst Tells Bloomberg
Nov 18, 2014 09:54 AM Teva Pharma (TEVA) Active, Shares Gain
Nov 18, 2014 09:16 AM Teva Pharma (TEVA) Launches Liquid Formulation of TREANDA Injection
Nov 18, 2014 09:07 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Nov 18
Nov 18, 2014 08:00 AM Teva Launches Liquid Formulation of TREANDA® (bendamustine HCI) Injection in U.S.
Nov 10, 2014 08:12 AM Teva Pharma (TEVA) PT Raised to $70 at Maxim Group
Nov 7, 2014 09:14 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Nov 07
Nov 7, 2014 09:02 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Nov 07
Nov 7, 2014 08:00 AM Teva Presents Data for Investigational Short-Acting Beta-Agonist Inhaler (Albuterol MDPI) at 2014 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology
Nov 7, 2014 08:00 AM Teva Presents Positive Safety and Efficacy Data for QNASL® (Beclomethasone Dipropionate) Nasal Aerosol in Treating Children with Perennial Allergic Rhinitis
Nov 4, 2014 09:40 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Nov 04
Nov 4, 2014 08:03 AM Teva Pharma (TEVA), Active Biotech Initiate ARPEGGIO Trial
Nov 4, 2014 08:00 AM Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington’s Disease Tria
Nov 3, 2014 08:09 AM RBC Capital Upgrades Teva Pharma (TEVA) to Outperform
Nov 3, 2014 07:00 AM BioTime’s Subsidiary Cell Cure Neurosciences Receives FDA Authorization to Initiate Phase I/IIa Trial of Embryonic Stem Cell-Derived OpRegen® for the Treatment of the Dry Form of Age-Related Macula
Oct 30, 2014 04:01 PM OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2014
Oct 30, 2014 02:00 PM Teva Pharma (TEVA) Price Target Raised to $64 at Deutsche Bank
Oct 30, 2014 10:32 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Oct 30
Oct 30, 2014 07:10 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Oct 30
Oct 30, 2014 07:04 AM Teva Pharma (TEVA) Tops Q3 EPS by 9c
Oct 30, 2014 07:03 AM Teva Reports Third Quarter 2014 Results
Oct 29, 2014 03:47 PM Trading Radar for 10/30: GoPro (GPRO), MasterCard (MA), LinkedIn (LNKD), Starbucks (SBUX) Report
Oct 14, 2014 12:48 PM Standpoint Research Upgrades Teva Pharma (TEVA) to Buy
Oct 9, 2014 04:07 PM Alexza Pharma (ALXA) Updates on Commercial Progress of ADASUVE in U.S. (TEVA)
Oct 8, 2014 10:06 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Oct 08
Oct 8, 2014 08:08 AM Teva Pharma (TEVA) Initiates Rolling NDA for CEP-33237
Oct 8, 2014 08:00 AM Teva Announces Initiation of New Drug Application and Positive Results from Second Human Abuse Liability Study for CEP-33237 (Hydrocodone Bitartrate) Extended-Release Tablets

Back to TEVA Stock Lookup